Center for Disease Control and Prevention. Tobacco Related Mortality. Accessed 10 November 2021. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/tobacco_related_mortality/index.htm.

United States Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress A Report of the Surgeon General. A Rep Surg Gen. 1081 (2014).

Danish Health Authority. Social ulighed i sundhed og sygdom 2010-2017 [Social inequality in health and disease in Denmark 2010-2017]. 1–263 (2020). https://www.sst.dk/-/media/Udgivelser/2020/Ulighed-i-sundhed/Social-ulighed-i-sundhed-og-sygdom-tilgaengelig.ashx.

Viegi, G. et al. Definition, epidemiology and natural history of COPD. Eur. Respir. J. 30, 993–1013 (2007).

CAS  PubMed  Article  Google Scholar 

Tashkin, D. P. & Murray, R. P. Smoking cessation in chronic obstructive pulmonary disease. Respir. Med. 103, 963–974 (2009).

PubMed  Article  Google Scholar 

Lundbäck, B. et al. Not 15 but 50% of smokers develop COPD?−Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir. Med. 97, 115–122 (2003).

PubMed  Article  Google Scholar 

Danish Health Authority. Anbefalinger for Tværsektorielle Forløb for Mennesker Med KOL / Recommentations for Cross-Sectorial Treatment of COPD. (2020).

Mirza, S., Clay, R. D., Koslow, M. A. & Scanlon, P. D. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin. Proc. 93, 1488–1502 (2018).

PubMed  Article  Google Scholar 

Tønnesen, P. Which drug to be used in smoking cessation? Pol. Arch. Med. Wewn. 118, 373–376 (2008).

PubMed  Google Scholar 

Anthonisen, N. R. et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1: The Lung Health Study. JAMA J. Am. Med. Assoc. 272, 1497–1505 (1994).

CAS  Article  Google Scholar 

Xu, X., Dockery, D. W., Ware, J. H., Speizer, F. E. & Ferris, B. G. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am. Rev. Respir. Dis. 146, 1345–1348 (1992).

CAS  PubMed  Article  Google Scholar 

Camilli, A. E., Burrows, B., Knudson, R. J., Lyle, S. K. & Lebowitz, M. D. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am. Rev. Respir. Dis. 135, 794–799 (1987).

CAS  PubMed  Article  Google Scholar 

Scanlon, P. D. et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the lung health study. Am. J. Respir. Crit. Care Med. 161, 381–390 (2000).

CAS  PubMed  Article  Google Scholar 

Godtfredsen, N. S. & Tønnesen, P. Rygestop og KOL [Smoking cessation and COPD]. Ugeskr. Laege. 175, 1266–1269 (2013).

Google Scholar 

Regions of Denmark. DrKOL Dansk register for Kronisk Obstruktiv Lungesygdom - National årsrapport 2018 [Danish Register of COPD. - National rapport 2018]. Regionernes Kliniske Kvalitetsudviklingsprogram. 2018. Accessed 10 November 2021. https://www.sundhed.dk/content/cms/90/4690_drkol-aarsrapport-2018_offentlig.pdf.

Tøttenborg, S. S., Thomsen, R. W., Johnsen, S. P., Nielsen, H. & Lange, P. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest 150, 554–562 (2016).

PubMed  Article  Google Scholar 

U.S. Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. 2012. https://www.ncbi.nlm.nih.gov/books/NBK99242/.

Çolak, Y., Afzal, S., Nordestgaard, B. G., Vestbo, J. & Lange, P. Prevalence, characteristics, and prognosis of early chronic obstructive pulmonary disease. the Copenhagen General Population Study. Am. J. Respir. Crit. Care Med. 201, 671–680 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Cahill, K. Stevens, S. Perera. R. & Lancaster, T. Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database Syst Rev. 2013;2013. https://doi.org/10.1002/14651858.CD009329.pub2.

Wang, R. J., Bhadriraju, S. & Glantz, S. A. E-cigarette use and adult cigarette smoking cessation: a meta-analysis. Am. J. Public Health 111, 230–246 (2021).

PubMed  PubMed Central  Article  Google Scholar 

Danish health authorities. Behandling af tobaksafhængighed - Anbefalinger til en styrket klinisk praksis [Treatment of tobacco dependance- recommendations to a good clinical practice]. https://www.sst.dk/da/udgivelser/2011/-/media/Udgivelser/2011/Publ2011/BOFO/Tobak/Behandling-af-tobaksafhængighed---Anbefalinger-til-en-styrket-klinisk-praksis.ashx.

Wagena, E. J., Knipschild, P. G., Huibers, M. J. H., Wouters, E. F. M. & Van Schayck, C. P. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch. Intern. Med. 165, 2286–2292 (2005).

CAS  PubMed  Article  Google Scholar 

Gonzales, D. et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. J. Am. Med. Assoc. 296, 47–55 (2006).

CAS  Article  Google Scholar 

Cahill, K., Lindson-Hawley, N., Thomas, K. H., Fanshawe, T. R. & Lancaster, T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst. Rev. 2016, 1–211 (2016).

Google Scholar 

Yilmazel Ucar, E. et al. Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic. Multidiscip. Respir. Med. 9, 9 (2014).

PubMed  PubMed Central  Article  Google Scholar 

Saylan, B., Baslilar, S. & Kartaloglu, Z. Comparative assessment of outcomes of smoking cessation therapies and role of free medications in successful long-term abstinence. Tob. Induc. Dis. 19, 51 (2021).

PubMed  PubMed Central  Article  Google Scholar 

Kocabas, A. & Ozyilmaz, E. The effects of socioeconomic status on health outcomes in patients with COPD. Eur. Respir. J. 48, PA1030 (2016).

Google Scholar 

Dautzenberg, B., Dautzenberg, M. Smoking cessation drugs in France: First effects of reimbursement under the general regime. Tobacco Prevention & Cessation, 5(Supplement), A65. https://doi.org/10.18332/tpc/105207 (2019).

Danish Health Authority. Forstærket indsats overfor storrygere 2014–2017 [Increased treatment of heavy smokers 2014–2017]. https://www.sst.dk/-/media/Puljer/Forstærket-indsats-over-for-storrygere/Slutevaluering.ashx?sc_lang=da&hash=84D4189F9EB1E66E80D28778FE63E25A.

Danish Health Authority. Hjælp til rygestop til særlige grupper (rygestopsmedicin) [Help to smoking cessation to special groups (smoking cessation medication)]. 2018. https://www.sst.dk/-/media/Udgivelser/2019/HJaelp-til-rygestop-til-saerlige-grupper-rygestopmedicin-evaluering.ashx.

Tibuakuu, M. et al. National trends in cessation counseling, prescription medication use, and associated costs among US adult cigarette smokers. JAMA Netw. open. 2, e194585 (2019).

PubMed  PubMed Central  Article  Google Scholar 

Tøttenborg, S. S., Clark, A. J., Thomsen, R. W., Johnsen, S. P. & Lange, P. Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study. Int. J. Copd. 13, 1775–1781 (2018).

Article  Google Scholar 

Fazleen, A. & Wilkinson, T. Early COPD: current evidence for diagnosis and management. Ther. Adv. Respir. Dis. 14, 1753466620942128 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Schmidt, M. et al. The Danish National patient registry: a review of content, data quality, and research potential. Clin. Epidemiol. 7, 449–490 (2015).

PubMed  PubMed Central  Article  Google Scholar 

Schmidt, M., Pedersen, L. & Sørensen, H. T. The Danish Civil Registration System as a tool in epidemiology. Eur. J. Epidemiol. 29, 541–549 (2014).

PubMed  Article  Google Scholar 

Wallach Kildemoes, H., Toft Sørensen, H. & Hallas, J. The Danish national prescription registry. Scand. J. Public Health 39, 38–41 (2011).

Article  Google Scholar 

World Health Organization. Anatomical Therapeutical Index -Classification. Accessed 20 April 2022. https://www.who.int/tools/atc-ddd-toolkit/atc-classification.

Statistics Denmark. SOCIO13. Accessed 20 April 2022. https://www.dst.dk/da/TilSalg/Forskningsservice/Dokumentation/hoejkvalitetsvariable/personers-tilknytning-til-arbejdsmarkedet-set-over-hele-aaret--akm-/socio13.

Andelius, D. K., Hilberg, O., Ibsen, R. & Løkke, A. National epidemiological case-control study of pharmacological smoking cessation treatment in Danish patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 16, 2433–2443 (2021).

PubMed  PubMed Central  Article  Google Scholar 

Prescott, E. & Vestbo, J. Socioeconomic status and chronic obstructive pulmonary disease. Thorax 54, 737 LP–737741 (1999).

Article  Google Scholar 

Carlone, S. et al. Health and social impacts of COPD and the problem of under-diagnosis. Multidiscip. Respir. Med. 9. https://doi.org/10.1186/2049-6958-9-63 (2014).

Pleasants, R. A., Riley, I. L. & Mannino, D. M. Defining and targeting health disparities in chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 2475–2496 (2016).

PubMed  PubMed Central  Article  Google Scholar 

Gershon, A. S., Dolmage, T. E., Stephenson, A. & Jackson, B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. J. Chronic Obstr. Pulm. Dis. 9, 216–226 (2012).

Article  Google Scholar 

Melzer, A. C. et al. Respiratory and bronchitic symptoms predict intention to quit smoking among current smokers with, and at risk for, chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 13, 1490–1496 (2016).

PubMed  PubMed Central  Article  Google Scholar 

Danish society of respiratory medicine. Treatment of COPD. Accessed 27 September 2021. https://lungemedicin.dk/kol-behandling/.

Gorin, S. S. & Heck, J. E. Meta-analysis of the efficacy of tobacco counseling by health care providers. Cancer Epidemiol. Biomark. Prev. 13, 2012–2022 (2004).

CAS  Article  Google Scholar 

Stead, L. F., Bergson, G. & Lancaster, T. Physician advice for smoking cessation. Cochrane Database Syst. Rev. 2, CD000165 (2008).

Google Scholar 

Jiménez-Ruiz, C. A. et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 119, 1365–1370 (2001).

PubMed  Article  Google Scholar 

Jiménez-Ruiz, C. A. et al. Cost-benefit analysis of funding smoking cessation before surgery. Br. J. Surg. 107, 978–994 (2020).

PubMed  Article  Google Scholar 

Jiménez-Ruiz, C. A. et al. Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 2027–2036 (2015).

PubMed  PubMed Central  Google Scholar 

van den Brand, F. A. et al. Does free or lower cost smoking cessation medication stimulate quitting? Findings from the International Tobacco Control (ITC) Netherlands and UK Surveys. Tob. Control. 28, s61–s67 (2019).

PubMed  Article  Google Scholar 

Fitzsimmons, K., Pechter, E. & Sparer-Fine, E. Chronic obstructive pulmonary disease and employment among Massachusetts adults. Prev. Chronic Dis. 17, E144 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Thornton Snider, J. et al. The disability burden of COPD. COPD 9, 513–521 (2012).

PubMed  Article  Google Scholar